Corient Private Wealth’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
+23,443
New +$123K ﹤0.01% 2900
2025
Q1
Sell
-10,000
Closed -$42.5K 2303
2024
Q4
$42.5K Hold
10,000
﹤0.01% 2288
2024
Q3
$29.4K Sell
10,000
-21,960
-69% -$69.9K ﹤0.01% 2422
2024
Q2
$111K Buy
31,960
+19,960
+166% +$66.6K ﹤0.01% 2200
2024
Q1
$34.2K Buy
12,000
+2,000
+20% +$6.17K ﹤0.01% 2244
2023
Q4
$35.3K Hold
10,000
﹤0.01% 2216
2023
Q3
$25.9K Hold
10,000
﹤0.01% 2101
2023
Q2
$39.4K Hold
10,000
﹤0.01% 2028
2023
Q1
$33.8K Hold
10,000
﹤0.01% 1961
2022
Q4
$35.8K Buy
+10,000
New +$42.7K ﹤0.01% 1648

Other funds holding SRTA

Corient Private Wealth's SRTA Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 23,443 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2900 among its holdings. This is a return to the name: Corient Private Wealth previously reported a position in SRTA as recently as Q4 2024.

Corient Private Wealth first reported a position in SRTA in Q4 2022 and has held it in 10 quarters since. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Corient Private Wealth held 23,443 shares of Strata Critical Medical Inc worth $124K as of Q2 2026.
  • Strata Critical Medical Inc was a new Corient Private Wealth position in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2900 holding.
  • Corient Private Wealth first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 10 quarters since.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.